Bivalirudin Injection 5 mg

Bivalirudin Injection 5 MG is an anticoagulant used to prevent blood clots during procedures. This intravenous solution is manufactured by Avir Pharma Inc. in Canada.

Bivalirudin Injection is primarily used to prevent blood clots in the bloodstream during certain medical procedures. It is often administered to patients undergoing percutaneous coronary intervention (PCI) or other procedures where anticoagulation is required. Bivalirudin works by inhibiting the action of thrombin, an enzyme that helps blood to clot. This medication is not typically used for long-term anticoagulation but is instead used for short-term prevention of clotting during specific procedures.

Common effects of Bivalirudin Injection may include bleeding at the injection site or other areas of the body. Some patients may experience bruising, nausea, or low blood pressure. These effects are generally mild and temporary, but any severe or persistent symptoms should be reported to a healthcare provider.

Bivalirudin Injection should be handled with care to avoid contamination. It is important to follow proper administration procedures to minimize the risk of bleeding. Patients with a history of bleeding disorders or recent surgery should use this medication with caution. Always consult a healthcare provider before use.

Bivalirudin Injection may interact with other anticoagulants, antiplatelet drugs, and nonsteroidal anti-inflammatory drugs (NSAIDs). Alcohol and certain herbal supplements may also affect its efficacy. It is important to inform your healthcare provider about all medications and supplements you are taking before starting Bivalirudin Injection.